Jinjing Liu

11PUBLICATIONS
15CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyAutoimmunityInnate immunityNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 02, 2025
Defective neutrophil-derived exosomes facilitate macrophage activation through miR-122-5p in Behçet's disease.

Xin Yu, Menghao Zhang, Na Kang

|Jan 03, 2025
Author Correction: TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease.

Menghao Zhang, Na Kang, Xin Yu

|Nov 27, 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial.

Jinjing Liu, Ying Jiang, Shangzhu Zhang

|Oct 27, 2024
TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease.

Menghao Zhang, Na Kang, Xin Yu

|Dec 25, 2023
Shelterin dysfunction promotes CD4+ T cell senescence in Behçet's disease.

Jing Shi, Menghao Zhang, Lili Zhang

|Jun 21, 2022
Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet's disease.

Wenjie Zheng, Xiaoman Wang, Jinjing Liu

Pageof 2

Frequent Collaborators

8 joint publications

Wenjie Zheng

2 joint publications

Xiaofeng Zeng

2 joint publications

Hua Chen

2 joint publications

Wanli Liu